Prosecution Insights
Last updated: November 12, 2026

Shenzhen Profound View Pharmaceutical Technology Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Shenzhen Profound View Pharmaceutical Technology Co. Ltd. has 2 pending office actions in Biotechnology & Pharmaceuticals. Each action is associated with a different examiner and a different art unit, producing 2 distinct examiners and 2 distinct art units.

INAM, SAHAR is the busiest examiner, with 1 pending matter. The record points to a fully distributed docket at the examiner level. A practitioner can use a coordinated technical position across the matters, but response preparation will need to account for each examiner’s separate treatment.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
§102 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
INAM, SAHAR 1 100.0% +0.0%
ALAWADI, SARAH 1 37.8% +38.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18725231 L-N-isobutyryl cysteine (L-NIBC)-bound gold cluster Au18(L-NIBC)14, compositions and applications thereof INAM, SAHAR —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18249253 GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL ISCHEMIC STROKES ALAWADI, SARAH 8d

Top Art Units

Art UnitApps
1622 1
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18725231 L-N-isobutyryl cysteine (L-NIBC)-bound gold cluster Au18(L-NIBC)14, compositions and applications thereof INAM, SAHAR 1622 §102 Non-Final OA — Pending Jun 28, 2024
18249253 GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL ISCHEMIC STROKES ALAWADI, SARAH 1619 §103Other Final Rejection 8d Pending Apr 18, 2023

Managing Shenzhen Profound View Pharmaceutical Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Shenzhen Profound View Pharmaceutical Technology Co. Ltd. have?

Shenzhen Profound View Pharmaceutical Technology Co. Ltd. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Shenzhen Profound View Pharmaceutical Technology Co. Ltd. applications?

Sahar Inam has the most, with 1 of Shenzhen Profound View Pharmaceutical Technology Co. Ltd.'s pending office actions.

What technology area are Shenzhen Profound View Pharmaceutical Technology Co. Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month